Table 2.
Events in 6‐year Follow‐up in Groups With Different MmiR‐126 Levels*
| Event | Total (n=176) | Low MmiR‐126 Level (n=88) | High Mmir‐126 Level (n=88) | P Value |
|---|---|---|---|---|
| Cardiovascular mortality | 13 (7.4) | 10 (11.4) | 3 (3.4) | 0.044 |
| All‐cause mortality | 27 (15.3) | 16 (18.2) | 11 (12.5) | 0.296 |
| Nonfatal myocardial infarction | 6 (3.4) | 6 (6.8) | 0 (0) | 0.029 |
| PCI | 33 (18.8) | 22 (25) | 11 (12.5) | 0.034 |
| CABG | 10 (5.7) | 5 (5.7) | 5 (5.7) | 1 |
| Revascularization | 43 (24.4) | 27 (30.7) | 16 (18.2) | 0.054 |
| First MACE | 55 (31.3) | 36 (40.9) | 19 (21.6) | 0.006 |
Data are shown as number (percentage). CABG indicates coronary artery bypass graft; MACE, major adverse cardiovascular event; MmiR, microRNA in circulating microvesicles; PCI, percutaneous coronary intervention.
*
According to the median of MmiR‐126.